Eventide Asset Management, LLC Guardant Health, Inc. Transaction History
Eventide Asset Management, LLC
- $4.71 Billion
- Q1 2025
A detailed history of Eventide Asset Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 3,566,738 shares of GH stock, worth $140 Million. This represents 3.23% of its overall portfolio holdings.
Number of Shares
3,566,738
Previous 3,807,937
6.33%
Holding current value
$140 Million
Previous $116 Million
30.61%
% of portfolio
3.23%
Previous 2.23%
Shares
13 transactions
Others Institutions Holding GH
# of Institutions
392Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$440 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$213 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$202 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$198 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...